Over the past 2 decades, the range of *Ixodes scapularis*, the deer tick, vector of Lyme disease, anaplasmosis, babesiosis, and deer tick virus infections, has expanded in northern New England. Because Lyme disease and anaplasmosis affect humans and dogs (*Canis lupus familiaris*), serosurveys of canids have proved useful for monitoring emergence of these infections. Sample selection may be confounded when dogs that are remotely exposed, vaccinated, or treated with topical acaricides are included. In recent years, however, the advent of a multitarget, in-clinic test kit (SNAP 4Dx; IDEXX Laboratories, Westbrook, ME, USA) has increased the scope and efficiency of these serosurveys. The SNAP 4Dx tests for heartworm antigen and antibodies to *Borrelia burgdorferi*, *Anaplasma phagocytophilum*, and *Ehrlichia canis* on 3 drops of blood. Its sensitivity and specificity for antibodies against *B. burgdorferi* and *A. phagocytophilum* exceed 98% ([@R1]*,*[@R2]).

In Maine, deer ticks were first reported at a coastal site in 1988 and have since spread inland ([@R3]). Lyme disease has become a major public health problem; reported human cases reached 169 per 100,000 population in 1 mid-coastal county in 2008. Human cases of anaplasmosis and babesiosis are also being reported ([@R4]). In 1990, we conducted a statewide serosurvey to map *B. burgdorferi*--positive dogs and to correlate their distribution with reported human cases. Four percent of 828 samples were seropositive for *B. burgdorferi*, 89% of which were from dogs residing within 20 miles of the coast. No positivity was found among 102 dogs in the northern half of the state ([@R5]). Given the widespread acceptance of SNAP 4Dx tests by Maine veterinarians, we resurveyed dogs statewide in 2007 for exposure to *B. burgdorferi* and *A. phagocytophilum.* Data from questionnaires to veterinarians and dog owners enabled assessment of the influence of the use of Lyme vaccines and topical acaricides on canine serologic test results.

The Study
=========

From 87 veterinary clinics solicited in 2007, we selected 47 on the basis of their size and geographic distribution. Each was supplied with 15--30 SNAP 4Dx kits (contributed by IDEXX Laboratories). Veterinarians were instructed to obtain samples from all dogs routinely tested for heartworm. In northern areas, where heartworm is rarely tested for, they were asked to collect samples from dogs undergoing surgery. They recorded each dog's age, town of residence, Lyme disease vaccination status (ever or never vaccinated), and the test results. Each dog owner completed a form (99.6% response rate) to describe the dog, its function, history of unexplained lameness, travel history (town, state, visited within the past year), history of tick infestation, and use of tick control products (yes or no).

We summarized test results to town and county levels. We used Spearman rank correlation tests to examine associations between canine seropositivity, human Lyme disease cases reported to the Maine Center for Disease Control and Prevention (Augusta, ME, USA) ([@R4]), and the number of deer ticks submitted to our laboratory in 2007. We used *B. burgdorferi* and *A. phagocytophilum* test results and questionnaire responses to cross-tabulate responses and calculate the likelihood (odds ratios) of *B. burgdorferi* and *A. phagocytophilum* positivity as a function of risk factors by using χ^2^ tests of association. We considered differences significant at p[\<]{.ul}0.05. Analyses were conducted by using SAS version 9.2 for Windows (SAS, Cary, NC, USA).

Of 1,087 dogs tested across Maine's 16 counties, 12.7% were *B. burgdorferi*--positive and 7.1% were *A. phagocytophilum*--positive ([Table 1](#T1){ref-type="table"}); 1.9% were co-infected. The distribution of all dogs seropositive for either pathogen is shown by town in [Figure 1](#F1){ref-type="fig"}. At the county level, canine *B. burgdorferi* seropositivity among unvaccinated dogs correlated positively with the number of human Lyme disease cases reported for 2007(ρ~Spearman~ = 0.84; p\<0.0001) and the number of deer ticks submitted to our laboratory for identification (ρ~Spearman~ = 0.63; p = 0.009). In [Figure 2](#F2){ref-type="fig"}, which shows statewide distributions by county north to south, only unvaccinated dogs are included in *B. burgdorferi*--positive data shown. Dogs had been exposed to *A. phagocytophilum* in all but 2 northern counties. At the town level, remarkably higher levels of canine *A. phagocytophilum* seropositivity were found in southern coastal Cape Elizabeth (Cumberland County) (76.5%, n = 17) and York (York County) (58.0%, n = 19) than in towns in their immediate vicinity.

###### Canine seroprevalence of *Borrelia burgdorferi* and *Anaplasma phagocytophilum* and Lyme diseases vaccination status, Maine, USA, 2007

  -------------- ------------------ -------------------- ------------------ ------------------------ -------------------- --------------------------------- -- ------- ------------
  County         No. dogs tested    *B. burgdorferi*\*                      *A. phagocytophilum*\*                        Lyme disease vaccination status              
  No. negative   No. (%) positive   No. negative         No. (%) positive   No. reporting            No. (%) vaccinated                                                
  Aroostook      59                 56                   3 (5.1)                                     59                   0                                    59      9 (15.3)
  Piscataquis    46                 44                   2 (4.3)                                     43                   3 (6.5)                              44      23 (52.3)
  Somerset       57                 55                   2 (3.5)                                     54                   3 (5.3)                              55      33 (60.0)
  Penobscot      77                 73                   4 (5.2)                                     73                   4 (5.2)                              75      30 (40.0)
  Franklin       78                 73                   5 (6.4)                                     78                   0                                    78      38 (48.7)
  Washington     38                 35                   3 (7.9)                                     37                   1 (2.6)                              37      6 (16.2)
  Hancock        54                 46                   8 (14.8)                                    53                   1 (1.9)                              54      24 (44.4)
  Oxford         76                 66                   10 (13.2)                                   75                   1 (1.3)                              76      41 (53.9)
  Waldo          62                 57                   5 (8.1)                                     60                   2 (3.2)                              62      38 (61.3)
  Kennebec       120                106                  14 (11.7)                                   114                  6 (5.0)                              119     82 (68.9)
  Knox           87                 67                   20 (23.0)                                   83                   4 (4.6)                              81      44 (54.3)
  Lincoln        91                 75                   16 (17.6)                                   85                   6 (6.6)                              85      63 (74.1)
  Androscoggin   62                 53                   9 (14.5)                                    60                   2 (3.2)                              62      27 (43.5)
  Sagadahoc      24                 22                   2 (8.3)                                     23                   1 (4.2)                              24      21 (87.5)
  Cumberland     91                 78                   13 (14.3)                                   72                   19 (20.9)                            88      62 (70.5)
  York           65                 42                   22 (34.4)                                   41                   24 (36.9)                            59      34 (57.6)
  Total          1,087              948                  138 (12.7)                                  1,010                77 (7.1)                             1,058   575 (54.3)
  -------------- ------------------ -------------------- ------------------ ------------------------ -------------------- --------------------------------- -- ------- ------------

\*Tested by using SNAP 4Dx test kit (IDEXX Laboratories, Westbrook, ME, USA).

![Towns where dogs were tested for seropositivity to *Borrelia burgdorferi* (A) and *Anaplasma phagocytophilum* (B) in a statewide serosurvey of domestic dogs, Maine, USA, 2007.](10-0408-F1){#F1}

![A) Canine seroprevalence for *Anaplasma phagocytophilum* and, in dogs never vaccinated against Lyme disease, for *Borrelia burgdorferi* in Maine counties arranged north to south, 2007. B) Maine counties, with the 10 tick-abundant counties used in the analyses shaded in gray. Counties: 1, Aroostook; 2, Piscataquis; 3, Somerset; 4, Penobscot; 5, Franklin; 6, Washington; 7, Hancock; 8, Oxford; 9, Waldo; 10, Kennebec; 11, Knox; 12, Lincoln; 13, Androscoggin; 14, Sagadahoc; 15, Cumberland; 16, York.](10-0408-F2){#F2}

Overall, 54.3% of the dogs had been vaccinated against Lyme disease. Never-vaccinated dogs were 1.5× as likely to be seropositive for *B. burgdorferi* than were vaccinated dogs (15.3% vs. 9.9%; p = 0.008) ([Table 2](#T2){ref-type="table"}). Vaccine use was higher in 10 southern counties where Lyme disease has become endemic ([Figure 2](#F2){ref-type="fig"}, panel B) than in the 6 northern counties where it is emerging (63.9% vs. 42.7%; p\<0.0001) and correlated positively with the number of deer ticks submitted to our laboratory for identification in 2007 (n = 16 counties, ρ~Spearman~ = 0.63; p = 0.009). Two thirds of respondents said that their dogs had traveled out of town; however, no associations were found between *B. burgdorferi* or *A. phagocytophilum* seropositivity and the dog's travel history. Three of 59 dogs in the northernmost county of Maine were *B. burgdorferi*--positive, 1 of which had never traveled beyond its home town. Eighty-three percent of owners reported using acaricides. Despite the effective protection reported for topical acaricides ([@R6]*,*[@R7]), no difference in seropositivity between treated and untreated dogs was evident on the basis of their reported use ([Table 2](#T2){ref-type="table"}). Unexplained lameness was 1.5× more likely in dogs that were only *A. phagocytophilum*--positive than in those only *B. burgdorferi*--positive (40.0% vs. 26.5%; p*\<*0.06).

###### Risk factors vs. canine seroprevalence of *Anaplasma phagocytophilum* and *Borrelia burgdorferi*, Maine, USA, 2007\*

  Variable                          No. dogs      *Borrelia burgdorferi*                      *Anaplasma phagocytophilum*                                           
  --------------------------------- ------------- ------------------------ ------------------ ----------------------------- ---------- ----------- ---------------- ----------
  No. (%) positive                  OR (95% CI)   p value†                 No. (%) positive   OR (95% CI)                   p value†                                
  Lyme vaccine                                                                                                                                                      
  Yes                               575           57 (9.9)                                                                             49 (8.5)                     
  No                                483           75 (15.3)                1.5 (1.1--2.1)     0.008                                    23 (4.8)    0.6 (0.3--0.9)   0.02
  Travel‡                                                                                                                                                           
  All dogs                                                                                                                                                          
  None                              357           49 (13.7)                                                                            27 (7.6)                     
  [\>]{.ul}1                        730           89 (12.2)                0.9 (0.6--1.3)     NS                                       50 (6.9)    0.9 (0.6--1.5)   NS
  Unvaccinated dogs                                                                                                                                                 
  None                              163           21 (12.9)                                                                            8 (4.9)                      
  [\>]{.ul}1                        320           53 (16.6)                1.3 (0.8--2.3)     NS                                       15 (4.7)    0.9 (0.4--2.3)   NS
  Tick control products                                                                                                                                             
  All dogs                                                                                                                                                          
  No                                182           20 (11.0)                                                                            7 (3.9)                      
  Yes                               899           115 (12.9)               1.2 (0.7--2.0)     NS                                       66 (7.4)    2.0 (0.9--4.4)   0.08
  Unvaccinated dogs                                                                                                                                                 
  No                                124           13 (10.5)                                                                            3 (2.4)                      
  Yes                               350           59 (16.9)                1.7 (0.9--3.3)     0.09                                     18 (5.1)    2.2 (0.6--7.6)   NS
  History of unexplained lameness                                                                                                                                   
  No                                877           97 (11.1)                                                                            42 (4.8)                     
  Yes                               191           40 (20.9)                2.1 (1.4--3.2)     0.0002                                   28 (15.2)   3.6 (2.1--5.9)   \<0.0001

\*A total of 1,087 dogs were tested. OR, odds ratio; CI, confidence interval; NS, not significant. †Significance based on Pearson χ^2^ statistic with 1 degree of freedom. ‡Trips away from town of residence.

Conclusions
===========

This study demonstrates that risk of contracting Lyme disease has reached northernmost Maine and that anaplasmosis is now being transmitted to dogs throughout the lower half of the state. The study expands on nationwide SNAP 4Dx data documenting *B. burgdorferi* and *A. phagocytophilum* positivity in the southern half of the state ([@R8]). In southern coastal Maine, overabundant white-tail deer, appropriate habitat, and maritime climate all contribute to high densities of *I. scapularis* ticks ([@R3]) and consequent disease transmission; thus, the remarkably high level of *A. phagocytophilum* seroreactivity observed in the southern coastal towns of Cape Elizabeth and York calls for further work to understand the dynamics of the intense local emergence of this pathogen. The higher level of unexplained lameness in *A. phagocytophilum*--positive dogs than in *B. burgdorferi*--positive dogs is consistent with findings by Beall et al. ([@R9]), who reported a 2.6× greater incidence of *A. phagocytophilum* seroreactivity than *B. burgdorferi* seroreactivity among 32 lame, non--co-infected dogs in Minnesota who were suspected of having either disease. The lameness also reflects the high percentage of *B. burgdorferi* positivity among asymptomatic dogs ([@R10]). That *B. burgdorferi* and *A. phagocytophilum* seropositivity rates were essentially identical between dogs who had a history of travel and those who did not lessens concern about travel as a confounding variable, an exposure difficult to interpret in any event, given the spotty distribution of ticks even where Lyme disease is endemic ([@R11]).

In a recent study, Hamer et al. ([@R12]) reported that a serosurvey of canines for *B. burgdorferi* is ineffective in a region that includes areas with little *B. burgdorferi* transmission, and less informative than analysis of ticks removed from dogs. The authors referred to the confounding influence of tick chemoprophylaxis. Our inability to detect an effect of topical acaricides may reflect their ubiquitous use for flea control and a lack of information on the frequency of their use. Although the widespread use of protective measures now complicates interpretation of serosurveys of canines, in selected dogs the availability of a reliable, multitarget test that is used routinely nationwide ([@R8]) remains a valuable and cost-effective method for documenting transmission of the agents of Lyme borreliosis and anaplasmosis, particularly in areas where disease is emerging.
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